Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,614.00
(
-0.45%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
105.25
(
0.78%
)
Bitcoin
70,700.00
(
1.15%
)
News Focus
News Focus
Post# of 1367
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 28
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: genisi post# 966

Thursday, 08/21/2008 6:43:33 AM

Thursday, August 21, 2008 6:43:33 AM

Post# of 1367
Kamada reported yesterday interim safety results of its 2nd phase II study with inhaled AAT, for the treatment of CF. Not a pip on efficacy. A CC on Mon.
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now